JD Health International Inc. (HKG: 6618)
Hong Kong
· Delayed Price · Currency is HKD
27.30
+0.75 (2.82%)
Jan 6, 2025, 4:08 PM HKT
JD Health International Revenue
JD Health International had revenue of 28.34B CNY in the half year ending June 30, 2024, with 40.14% growth. This brings the company's revenue in the last twelve months to 54.76B, up 2.13% year-over-year. In the year 2023, JD Health International had annual revenue of 53.53B with 14.54% growth.
Revenue (ttm)
54.76B CNY
Revenue Growth
+2.13%
P/S Ratio
1.45
Revenue / Employee
17.56M CNY
Employees
3,118
Market Cap
87.32B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
CSPC Pharmaceutical Group | 33.53B |
Akeso | 2.01B |